APPLICATION
NDA018200
TYPE
NDA
ORIGINAL APPROVAL
1981-10-05
LATEST ACTION
2003-02-25
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
MIDAMOR · ReferencePrescription
AMILORIDE HYDROCHLORIDE 5MG · TABLET · ORAL
Approval history
2002-06-24Manufacturing (CMC) · Supplement 25 · standardAP
2001-09-18Labeling · Supplement 23 · standardAP
2000-11-21Manufacturing (CMC) · Supplement 22 · standardAP
1998-02-12Manufacturing (CMC) · Supplement 21 · standardAP
1992-09-16Labeling · Supplement 20AP
1992-03-26Manufacturing (CMC) · Supplement 19 · standardAP
1991-05-14Manufacturing (CMC) · Supplement 18 · standardAP
1989-04-12Labeling · Supplement 17AP
1988-06-22Manufacturing (CMC) · Supplement 13 · standardAP
1988-05-05Labeling · Supplement 10AP
1988-03-29Manufacturing (CMC) · Supplement 16 · standardAP
1987-06-01Manufacturing (CMC) · Supplement 15 · standardAP
1987-03-09Manufacturing (CMC) · Supplement 14 · standardAP
1986-01-21Labeling · Supplement 12AP
1985-11-01Labeling · Supplement 11AP
1985-09-10Manufacturing (CMC) · Supplement 9 · standardAP
1985-06-14Labeling · Supplement 8AP
1985-02-07Labeling · Supplement 7AP
1984-01-04Manufacturing (CMC) · Supplement 6 · standardAP
1983-12-23Manufacturing (CMC) · Supplement 5 · standardAP
1983-03-01Manufacturing (CMC) · Supplement 4 · standardAP
1982-07-08Manufacturing (CMC) · Supplement 3 · standardAP
1982-03-03Manufacturing (CMC) · Supplement 2 · standardAP
1982-02-08Manufacturing (CMC) · Supplement 1 · standardAP
1981-10-05Type 1 - New Molecular Entity · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.